Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
24.70
-0.12 (-0.48%)
Feb 11, 2026, 1:31 PM HKT
Market Cap8.37B +131.3%
Revenue (ttm)984.51M +35.4%
Net Income167.21M +495.0%
EPS0.51 +495.2%
Shares Out337.34M
PE Ratio48.76
Forward PE31.19
Dividend0.11 (0.44%)
Ex-Dividend Daten/a
Volume331,000
Average Volume649,165
Open25.00
Previous Close24.82
Day's Range24.52 - 25.20
52-Week Range11.68 - 28.00
Beta0.48
RSI51.85
Earnings DateMar 20, 2026

About HKG:2190

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. Its peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as cover... [Read more]

Sector Healthcare
Founded 2012
Employees 875
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2190
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements